Clinical Trials Directory

Trials / Sponsors / Cougar Biotechnology, Inc.

Cougar Biotechnology, Inc.

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic C
Prostate Neoplasms, Prostate Cancer
Phase 12011-09-01
CompletedA Study to Assess the Relative Bioavailability of Two Abiraterone Acetate Suspension Formulations Compared to
Healthy Volunteers
Phase 12011-05-01
CompletedNeo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer
Prostate Cancer
Phase 22009-12-01
CompletedA Study to Determine the Effect of Food on the Pharmacokinetics of Abiraterone Acetate in Healthy Male Patient
Healthy Volunteers
Phase 12009-09-01
CompletedA Pharmacokinetic Study of Abiraterone Acetate in Male Participants With Impaired Renal Function Compared to I
Renal Insufficiency
Phase 12009-08-01
CompletedA Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairm
Prostate Cancer
Phase 12009-08-01
CompletedAbiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemothera
Prostatic Neoplasms
Phase 32008-05-01
TerminatedA Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma
Refractory Multiple Myeloma
Phase 12007-12-01
CompletedA Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prosta
Prostate Neoplasms
Phase 12007-07-01
CompletedAn Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Fa
Prostatic Neoplasms, Prostate Cancer
Phase 22007-06-01
CompletedAn Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed A
Prostate Neoplasms
Phase 22006-11-01
CompletedA Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormon
Prostatic Neoplasms
Phase 1 / Phase 22005-11-01